Protein expression knockdown in cancer cells induced by a gemini cationic lipid nanovector with histidine-based polar heads

A histidine-based gemini cationic lipid, which had already demonstrated its efficiency as a plasmid DNA (pDNA) nanocarrier, has been used in this work to transfect a small interfering RNA (siRNA) into cancer cells. In combination with the helper lipid monoolein glycerol (MOG), the cationic lipid was...

Descripción completa

Detalles Bibliográficos
Autores: Sánchez Arribas, Natalia, Martínez Negro, María, Villar; Eva M., Pérez, Lourdes, Osío Barcina, José De Jesús, Aicart Sospedra, Emilio, Taboada, Pablo, Guerrero Martínez, Andrés, Junquera González, María Elena
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/108924
Acceso en línea:https://hdl.handle.net/20.500.14352/108924
Access Level:acceso abierto
Palabra clave:544
577.1
Non-viral gene delivery
Gene knockdown efficiency
Small interfering RNA
Amino acid-based gemini cationic lipids
Protein expression
Protein corona
Química física (Química)
Bioquímica (Química)
2307 Química Física
2302.26 Bioquímica Física
Descripción
Sumario:A histidine-based gemini cationic lipid, which had already demonstrated its efficiency as a plasmid DNA (pDNA) nanocarrier, has been used in this work to transfect a small interfering RNA (siRNA) into cancer cells. In combination with the helper lipid monoolein glycerol (MOG), the cationic lipid was used as an antiGFP-siRNA nanovector in a multidisciplinary study. Initially, a biophysical characterization by zeta potential and agarose gel electrophoresis experiments was performed to determine the lipid effective charge and confirm siRNA compaction. The lipoplexes formed were arranged in Lalfa lamellar lyotropic liquid crystal phases with a cluster-type morphology, as cryo-transmission electron microscopy (cryo-TEM) and small-angle X-ray scattering (SAXS) studies revealed. Additionally, in vitro experiments confirmed the high gene knockdown efficiency of the lipid-based nanovehicle as detected by flow cytometry (FC) and epifluorescence microscopy, even better than that of Lipofectamine2000*, the transfecting reagent commonly used as a positive control. Cytotoxicity assays indicated that the nanovector is non-toxic to cells. Finally, using nano-liquid chromatography tandem mass spectrometry (nanoLC-MS/MS), apolipoprotein A-I and A-II followed by serum albumin were identified as the proteins with higher affinity for the surface of the lipoplexes. This fact could be beyond the remarkable silencing activity of the histidine-based lipid nanocarrier herein presented.